⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Rapport Therapeutics, Inc. Common Stock

$39.66
-0.72 (-1.78%)

Volume:

604.381K ($23.95M)

Market Capitalization:

$1.90B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Rapport Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.02(+0.05%)
Open$39.64
Close$39.66
Low$39.64
Low Change0.00 (0.00%)
High$39.66
High Change+0.02 (+0.05%)
Range$0.02
Volume101.59K
Dollar Volume$4.03M

Regular Trading Hours

-1.33(-3.25%)
Open$40.95
Close$39.62
Low$39.11
Low Change-1.84 (-4.49%)
High$42.18
High Change+1.23 (+3.00%)
Range$3.07
Volume502.791K
Dollar Volume$19.92M

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$40.45
Close$40.45
Low$40.45
Low Change0.00 (0.00%)
High$40.45
High Change+0.00 (+0.00%)
Range$0.00
Volume611.451K
Dollar Volume$24.73M

Regular Trading Hours Yesterday

-1.51(-3.60%)
Open$41.89
Close$40.38
Low$40.29
Low Change-1.61 (-3.83%)
High$43.00
High Change+1.11 (+2.65%)
Range$2.72
Volume283.234K
Dollar Volume$11.44M

Premarket Yesterday

+0.00(+0.00%)
Open$41.95
Close$41.95
Low$41.95
Low Change0.00 (0.00%)
High$41.95
High Change+0.00 (+0.00%)
Range$0.00
Volume205
Dollar Volume$8.60K

Rapport Therapeutics News

There is no current news for this stock at the moment.

Rapport Therapeutics Top Trades

Rapport Therapeutics's top trade so far today returned +3.00%, while the top short trade returned -6.07%.

Rapport Therapeutics Moving Averages

5 Day Moving Average (SMA5)$41.21
10 Day Moving Average (SMA10)$42.70
20 Day Moving Average (SMA20)$45.95
50 Day Moving Average (SMA50)$44.76
100 Day Moving Average (SMA100)$41.25
200 Day Moving Average (SMA200)$35.56

Rapport Therapeutics Statistics

Average Volume (30 Days)311.35K
P/E Ratio (Current)-14.14
EPS (Current)-$2.86
Dividend Yield0.00%
Free Cash Flow-$97.15M
Cash Ratio2.24
Current Ratio15.72
Quick Ratio15.72
Debt to Equity0.00
Enterprise Value$1.88B
EV to EBITDA-12.30
EV to Sales93.86
Price to Book4.59
Price to Cash Flow
Price to Free Cash Flow
Price to Sales97.04
Return on Assets-0.30%
Return on Equity-0.32%

Rapport Therapeutics Stock Splits

There have been no stock splits for Rapport Therapeutics (RAPP).

Rapport Therapeutics Dividends

There have been no dividends for Rapport Therapeutics (RAPP).